Bharat Biotech targets 1billion/year doses by 2021-end | India News – Times of India

Representative image

HYDERABAD: Amid a growing clamour for ramp-up of Covaxin capacity, its developer Bharat Biotech has decided to deploy its Chiron Behring facility in Gujarat to boost output by another 200 million doses annually.
This will scale up production to nearly 1 billion doses a year by 2021 end, a top Bharat Biotech executive said on Thursday. “The company plans to produce 200 million doses of Covaxin per annum,” Bharat Biotech joint MD Suchitra Ella tweeted about the new facility.

FacebookTwitterLinkedinEMail

Source link

Leave a Comment